BridgeMD
Effect of oxygen administration in the non-dependent lung on postoperative complications after lung surgery
EU CTIS ID: 2024-517599-39-00
What this study is testing
The main objective of the study is to compare the impact of three different techniques of oxygen administration applied to the non-ventilated lung during one-lung ventilation on the occurrence of postoperative complications.
- Therapeutic use (Phase IV)
A plain-language read of the study's public EU CTIS listing. The study team confirms the details.
Who can take part
You may be able to join if
- Patients over 18 years of age, legally competent, of both sexes, scheduled to undergo Lung Resection Surgery requiring lung isolation with a double-lumen tube. Voluntary acceptance to participate in the study and signing of informed consent.
You likely can't join if
- Patient with evidence of pulmonary bullae. Pregnancy or breastfeeding. Pneumonectomy. Blood product transfusion within 10 days prior to surgery. Treatment with immunosuppressants or corticosteroids within 3 months prior to surgery. History of contralateral thoracic surgery. Robotic surgery. Patient refusal. Patients included in another clinical trial
The study team makes the final eligibility decision.
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18-64 years, 65+ years. The study team makes the final eligibility decision.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from EU CTIS; the study team decides eligibility.